{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:58:54Z","timestamp":1777507134879,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"ISCIII-FOS","award":["FI19\/00090"],"award-info":[{"award-number":["FI19\/00090"]}]},{"name":"ISCIII-FEDER","award":["PI18\/00145"],"award-info":[{"award-number":["PI18\/00145"]}]},{"name":"ISCIII-FEDER","award":["PI18\/00145"],"award-info":[{"award-number":["PI18\/00145"]}]},{"DOI":"10.13039\/100006301","name":"CIBER","doi-asserted-by":"crossref","award":["ES18PI01X1-2021"],"award-info":[{"award-number":["ES18PI01X1-2021"]}],"id":[{"id":"10.13039\/100006301","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006301","name":"CIBER","doi-asserted-by":"crossref","award":["ES18PI01X1-2021"],"award-info":[{"award-number":["ES18PI01X1-2021"]}],"id":[{"id":"10.13039\/100006301","id-type":"DOI","asserted-by":"crossref"}]},{"name":"SEPAR","award":["208, 628, 1428"],"award-info":[{"award-number":["208, 628, 1428"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91368-3","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T22:04:21Z","timestamp":1740261861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Virulence factors of Pseudomonas aeruginosa and immune response during exacerbations and stable phase in bronchiectasis"],"prefix":"10.1038","volume":"15","author":[{"given":"Roberto","family":"Cabrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nona","family":"Rovira-Ribalta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Motos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"Bueno-Freire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nil","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Soler-Comas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Alcaraz-Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"L\u00f3pez-Aladid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laia","family":"Fern\u00e1ndez-Barat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"key":"91368_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/qjmed\/hcab129","volume":"115","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Isolated IgG2 deficiency is an independent risk factor for exacerbations in bronchiectasis. QJM: Mon. J. Associat. Physicians 115, 292\u2013297 (2022).","journal-title":"QJM: Mon. J. Associat. Physicians"},{"key":"91368_CR2","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/jac\/dkac084","volume":"77","author":"R Cabrera","year":"2022","unstructured":"Cabrera, R. et al. Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa strains from patients with bronchiectasis. J. Antimicrob. Chemother. 77, 1600\u20131610 (2022).","journal-title":"J. Antimicrob. Chemother."},{"key":"91368_CR3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1186\/s12879-020-05534-1","volume":"20","author":"B Alonso","year":"2020","unstructured":"Alonso, B. et al. Characterization of the virulence of Pseudomonas aeruginosa strains causing ventilator-associated pneumonia. BMC Infect. Dis. 20, 909 (2020).","journal-title":"BMC Infect. Dis."},{"key":"91368_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037459","volume":"7","author":"R Morales-Espinosa","year":"2012","unstructured":"Morales-Espinosa, R. et al. Genetic and phenotypic characterization of a Pseudomonas aeruginosa population with high frequency of genomic islands. PLoS One 7, e37459 (2012).","journal-title":"PLoS One"},{"key":"91368_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2017.05.001","volume":"128","author":"G Suarez-Cuartin","year":"2017","unstructured":"Suarez-Cuartin, G. et al. Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis. Respir. Med. 128, 1\u20136 (2017).","journal-title":"Respir. Med."},{"key":"91368_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ppul.10457","volume":"37","author":"HK Johansen","year":"2004","unstructured":"Johansen, H. K. et al. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: A marker of therapeutic success?\u2013A 30-year cohort study of survival in Danish CF patients after onset of chronic Pseudomonas aeruginosa lung infection. Pediatr. Pulmonol. 37, 427\u2013432 (2004).","journal-title":"Pediatr. Pulmonol."},{"key":"91368_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.arbr.2018.08.003","volume":"55","author":"A Padilla-Galo","year":"2019","unstructured":"Padilla-Galo, A. & Olveira Fuster, C. Bronchiectasis in COPD and Asthma. More than just a coincidence. Arch. Bronconeumol. (Engl. Ed.) 55, 181\u2013182 (2019).","journal-title":"Arch. Bronconeumol. (Engl. Ed.)"},{"key":"91368_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/2049-632X.12033","volume":"67","author":"SL Gellatly","year":"2013","unstructured":"Gellatly, S. L. & Hancock, R. E. W. Pseudomonas aeruginosa: New insights into pathogenesis and host defenses. Pathog. Dis. 67, 159\u2013173 (2013).","journal-title":"Pathog. Dis."},{"key":"91368_CR9","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1128\/JB.01688-06","volume":"189","author":"J Klockgether","year":"2007","unstructured":"Klockgether, J., W\u00fcrdemann, D., Reva, O., Wiehlmann, L. & T\u00fcmmler, B. Diversity of the abundant pKLC102\/PAGI-2 family of genomic islands in Pseudomonas aeruginosa. J. Bacteriol. 189, 2443\u20132459 (2007).","journal-title":"J. Bacteriol."},{"key":"91368_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/23744235.2017.1393839","volume":"50","author":"BM Ertugrul","year":"2018","unstructured":"Ertugrul, B. M., Oryasin, E., Lipsky, B. A., Willke, A. & Bozdogan, B. Virulence genes fliC, toxA and phzS are common among Pseudomonas aeruginosa isolates from diabetic foot infections. Infect. Dis. (Lond.) 50, 273\u2013279 (2018).","journal-title":"Infect. Dis. (Lond.)"},{"key":"91368_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13000-014-0158-z","volume":"9","author":"RM Mauch","year":"2014","unstructured":"Mauch, R. M. et al. Assessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA). Diagn. Pathol. 9, 158 (2014).","journal-title":"Diagn. Pathol."},{"key":"91368_CR12","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1128\/IAI.66.3.1000-1007.1998","volume":"66","author":"SK Arora","year":"1998","unstructured":"Arora, S. K., Ritchings, B. W., Almira, E. C., Lory, S. & Ramphal, R. The Pseudomonas aeruginosa flagellar cap protein, FliD, is responsible for mucin adhesion. Infect. Immun. 66, 1000\u20131007 (1998).","journal-title":"Infect. Immun."},{"key":"91368_CR13","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.21037\/jtd.2018.08.29","volume":"10","author":"JY Oh","year":"2018","unstructured":"Oh, J. Y. et al. Elevated interleukin-6 and bronchiectasis as risk factors for acute exacerbation in patients with tuberculosis-destroyed lung with airflow limitation. J. Thorac. Dis. 10, 5246\u20135253 (2018).","journal-title":"J. Thorac. Dis."},{"key":"91368_CR14","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.jand.2012.08.013","volume":"112","author":"G Olveira","year":"2012","unstructured":"Olveira, G. et al. Fat-free mass depletion and inflammation in patients with bronchiectasis. J. Acad. Nutr. Diet. 112, 1999\u20132006 (2012).","journal-title":"J. Acad. Nutr. Diet."},{"key":"91368_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2023.104174","volume":"52","author":"M Barbosa","year":"2023","unstructured":"Barbosa, M. & Chalmers, J. D. Bronchiectasis. Presse. Med. 52, 104174 (2023).","journal-title":"Presse. Med."},{"key":"91368_CR16","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.3390\/jcm9082631","volume":"9","author":"R Men\u00e9ndez","year":"2020","unstructured":"Men\u00e9ndez, R. et al. Systemic Inflammation during and after bronchiectasis exacerbations: Impact of Pseudomonas aeruginosa. J. Clin. Med. 9, 2631 (2020).","journal-title":"J. Clin. Med."},{"key":"91368_CR17","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1128\/JCM.42.12.5783-5792.2004","volume":"42","author":"S Finnan","year":"2004","unstructured":"Finnan, S., Morrissey, J. P., O\u2019Gara, F. & Boyd, E. F. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J. Clin. Microbiol. 42, 5783\u20135792 (2004).","journal-title":"J. Clin. Microbiol."},{"key":"91368_CR18","doi-asserted-by":"publisher","first-page":"19830","DOI":"10.1073\/pnas.0606810104","volume":"103","author":"X Qiu","year":"2006","unstructured":"Qiu, X., Gurkar, A. U. & Lory, S. Interstrain transfer of the large pathogenicity island (PAPI-1) of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 103, 19830\u201319835 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"91368_CR19","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1128\/IAI.01204-08","volume":"77","author":"C Chemani","year":"2009","unstructured":"Chemani, C. et al. Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands. Infect Immun 77, 2065\u20132075 (2009).","journal-title":"Infect Immun"},{"key":"91368_CR20","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.resmic.2013.06.007","volume":"164","author":"SM-C Petit","year":"2013","unstructured":"Petit, S.M.-C. et al. Lagooning of wastewaters favors dissemination of clinically relevant Pseudomonas aeruginosa. Res. Microbiol. 164, 856\u2013866 (2013).","journal-title":"Res. Microbiol."},{"key":"91368_CR21","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1099\/mic.0.2007\/011338-0","volume":"153","author":"JM Gaines","year":"2007","unstructured":"Gaines, J. M. et al. Regulation of the Pseudomonas aeruginosa toxA, regA and ptxR genes by the iron-starvation sigma factor PvdS under reduced levels of oxygen. Microbiology (Reading) 153, 4219\u20134233 (2007).","journal-title":"Microbiology (Reading)"},{"key":"91368_CR22","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1099\/mic.0.26822-0","volume":"150","author":"JV Kus","year":"2004","unstructured":"Kus, J. V., Tullis, E., Cvitkovitch, D. G. & Burrows, L. L. Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients. Microbiology (Reading) 150, 1315\u20131326 (2004).","journal-title":"Microbiology (Reading)"},{"key":"91368_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10123-018-00035-3","volume":"22","author":"G Horna","year":"2019","unstructured":"Horna, G. et al. Specific type IV pili groups in clinical isolates of Pseudomonas aeruginosa. Int. Microbiol. 22, 131\u2013141 (2019).","journal-title":"Int. Microbiol."},{"key":"91368_CR24","doi-asserted-by":"publisher","first-page":"7986234","DOI":"10.1155\/2016\/7986234","volume":"2016","author":"G-Q Wang","year":"2016","unstructured":"Wang, G.-Q. et al. Effect of negative pressure on proliferation, virulence factor secretion, biofilm formation, and virulence-regulated gene expression of pseudomonas aeruginosa in vitro. Biomed. Res. Int. 2016, 7986234 (2016).","journal-title":"Biomed. Res. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91368-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91368-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91368-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T22:04:27Z","timestamp":1740261867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91368-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91368"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91368-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all individual participants included in the study. Hospital Clinic ethical committee reference number: HCB\/2018\/0236.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"6520"}}